Biography:
Mizuho Sumitani studied medicine at University of Tsukuba in Japan graduating and obtaining her MD license in 2000. She then completed her training in otorhinolaryngology, head and neck cancer oncology, and supportive and palliative care at Yokohama City University. While working as a clinical otolaryngologist, she has been investigating several types of genetic association studies on cancer pain and opioid sensitivity to improve the quality of life of cancer patients.
Title : Astrotactin 2 as novel analgesic target candidate for cancer pain and opioid sparing: An exploratory genetic polymorphism analysis